Bristol-Myers Squibb Company (BMY)
NYSE: BMY · Real-Time Price · USD
57.13
+0.23 (0.40%)
At close: Jun 12, 2026, 4:00 PM EDT
57.11
-0.02 (-0.04%)
After-hours: Jun 12, 2026, 7:59 PM EDT

BMY Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21
11,48912,50212,22212,26911,20112,34211,89212,20111,86511,47710,96611,22611,33711,40611,21811,88711,64811,98511,62411,703
Revenue Growth (YoY)
2.57%1.30%2.77%0.56%-5.60%7.54%8.44%8.69%4.66%0.62%-2.25%-5.56%-2.67%-4.83%-3.49%1.57%5.19%8.29%10.29%15.54%
Cost of Revenue
3,4214,0973,4353,3723,0334,8122,9573,2672,9322,7452,5062,8762,5662,5932,3532,7202,4712,3562,2912,452
Gross Profit
8,0688,4058,7878,8978,1687,5308,9358,9348,9338,7328,4608,3508,7718,8138,8659,1679,1779,6299,3339,251
Selling, General & Admin
1,6172,1811,7891,7131,5842,1361,9831,9282,367-2,0031,9341,7622,2661,9301,7871,8312,3541,7881,882
Depreciation & Amortization Expenses
4378268318308301,6932,4062,4162,3572,2782,2562,2572,2562,3432,4182,4172,4172,4172,5462,547
Research & Development
2,7433,9793,1614,0882,4453,2212,6363,03115,6443,0782,3222,4162,3962,5622,4482,7212,5932,6073,2513,271
Total Operating Expenses
4,7976,9865,7816,6314,8597,0507,0257,37520,3685,3566,5816,6076,4147,1716,7966,9256,8417,3787,5857,700
Operating Income
3,2711,4193,0062,2663,3094801,9101,559-11,4353,3761,8791,7432,3571,6422,0692,2422,3362,2511,7481,551
Total Non-Operating Income (Expense)
-3251108-494-339-305-234-273-81371258116413217140-284-649-3934092
Pretax Income
3,2401,4703,1141,7732,9711751,6761,286-11,5161,6742,1371,8592,7701,8592,2091,9581,6871,8582,1571,553
Provision for Income Taxes
56138491946050999461-398392-88203-218503-166601529404-514605492
Net Income
2,6781,0852,1951,3132,462761,2151,684-11,9081,7621,9342,0772,2672,0251,6081,4291,2832,3721,5521,061
Minority Interest in Earnings
1---6---------------
Net Income to Common
2,6771,0852,1951,3132,456761,2151,684-11,9081,7621,9342,0772,2672,0251,6081,4291,2832,3721,5521,061
Net Income Growth
9.00%1327.63%80.66%-22.03%--95.69%-37.18%-18.92%--12.99%20.27%45.35%76.70%-14.63%3.61%34.68%-36.77%--17.36%-
Shares Outstanding (Basic)
2,0382,0362,0362,0352,0312,0292,0282,0272,0232,0272,0572,0932,0992,1082,1332,1332,1462,2022,2432,252
Shares Outstanding (Diluted)
2,0472,0412,0392,0382,0402,0372,0312,0292,0232,0332,0642,1022,1132,1242,1482,1492,1642,2192,2432,252
Shares Change (YoY)
0.34%0.20%0.39%0.44%0.84%0.20%-1.60%-3.47%-4.26%-4.28%-3.91%-2.19%-2.36%-4.28%-4.23%-4.57%-4.46%-1.47%-2.05%-0.49%
EPS (Basic)
1.310.531.080.641.210.040.600.83-5.890.870.940.991.080.960.750.670.601.080.690.47
EPS (Diluted)
1.310.531.080.641.200.040.600.83-5.890.870.930.991.070.950.750.660.591.070.690.47
EPS Growth
9.17%1225.00%80.00%-22.89%--95.40%-35.48%-16.16%--8.42%24.00%50.00%81.36%-11.21%8.70%40.43%-33.71%--15.85%-
Free Cash Flow
7571,6045,9913,5561,6944,0615,2672,0642,5503,9224,4091,6282,6922,9603,4401,9893,5593,7374,9962,850
Free Cash Flow Growth
-55.31%-60.50%13.75%72.29%-33.57%3.54%19.46%26.78%-5.27%32.50%28.17%-18.15%-24.36%-20.79%-31.14%-30.21%-2.52%21.65%141.82%-31.13%
Free Cash Flow Per Share
0.370.792.941.740.831.992.591.021.261.932.140.771.271.391.600.931.641.682.231.27
Dividends Per Share
0.6300.6300.6200.6200.6200.6200.6000.6000.6000.6000.5700.5700.5700.5700.5400.5400.5400.5400.4900.490
Dividend Growth
1.61%1.61%3.33%3.33%3.33%3.33%5.26%5.26%5.26%5.26%5.56%5.56%5.56%5.56%10.20%10.20%10.20%10.20%8.89%8.89%
Gross Margin
70.22%67.23%71.89%72.52%72.92%61.01%75.13%73.22%75.29%76.08%77.15%74.38%77.37%77.27%79.02%77.12%78.79%80.34%80.29%79.05%
Operating Margin
28.47%11.35%24.59%18.47%29.54%3.89%16.06%12.78%-96.38%29.42%17.13%15.53%20.79%14.40%18.44%18.86%20.05%18.78%15.04%13.25%
Profit Margin
23.31%8.68%17.96%10.70%21.98%0.62%10.22%13.80%-100.36%15.35%17.64%18.50%20.00%17.75%14.33%12.02%11.01%19.79%13.35%9.07%
FCF Margin
6.59%12.83%49.02%28.98%15.12%32.90%44.29%16.92%21.49%34.17%40.21%14.50%23.75%25.95%30.66%16.73%30.55%31.18%42.98%24.35%
EBITDA
3,8652,3964,0173,2774,3212,3604,5024,155-8,9035,8404,3144,1754,7864,1634,6574,8254,9204,8304,4754,263
EBITDA Margin
33.64%19.16%32.87%26.71%38.58%19.12%37.86%34.05%-75.04%50.88%39.34%37.19%42.22%36.50%41.51%40.59%42.24%40.30%38.50%36.43%
EBIT
3,2711,4193,0062,2663,3094801,9101,559-11,4353,3761,8791,7432,3571,6422,0692,2422,3362,2511,7481,551
EBIT Margin
28.47%11.35%24.59%18.47%29.54%3.89%16.06%12.78%-96.38%29.42%17.13%15.53%20.79%14.40%18.44%18.86%20.05%18.78%15.04%13.25%
Effective Tax Rate
17.31%26.12%29.51%25.94%17.13%56.57%27.51%-30.95%-3.40%-5.26%9.50%-11.73%18.16%-8.93%27.21%27.02%23.95%-27.66%28.05%31.68%
SEC Filings: 10-K · 10-Q